BofA clients continue selling the S&P 500 rally By Investing.com

Bank of America reported a sixth straight week of single-stock outflows totaling $3.9 billion, only partly offset by $1.4 billion of ETF inflows, as the S&P 500 rose 0.5%. Institutional clients drove most of the selling, while large caps posted seven straight weeks of combined stock and ETF outflows. Sector flows were broadly negative, with Health Care the weakest and Energy extending its selling streak to eight weeks, though Tech saw inflows ahead of a heavy earnings week.

Analysis

The flow profile suggests a market that is still being bought mechanically but not embraced fundamentally. That matters because when discretionary institutions keep selling into ETF demand, the marginal buyer shifts from active capital to passive rebalance, which usually leaves index-level resilience intact while broadening under the surface. In practice, that is a weaker tape than the headline S&P move implies, and it raises the odds that leadership narrows further into the few names with visible near-term catalysts.

The most important second-order effect is that the current rotation is not symmetric. Tech is attracting capital ahead of earnings, but if results merely meet expectations, positioning can unwind quickly because a lot of the bid is anticipatory rather than thesis-driven. By contrast, Health Care’s sustained selling looks more structural than cyclical, which can create delayed opportunities in profitable large-cap defensives once the forced de-risking exhausts itself; the setup favors mean reversion over immediate momentum.

Buyback deceleration is a real watch item because it removes a source of price-insensitive demand just as natural buyer conviction remains weak. The firms still accelerating repurchases in Financials and Energy are likely to outperform on relative support, while Tech’s slowdown in capital return could make the sector more dependent on earnings beats and guidance upgrades. If buybacks continue to lag for another quarter, index support becomes increasingly reliant on ETF flows, which is fragile if volatility picks up around megacap results or the Fed.

The contrarian read is that the market may be overestimating how bullish the recent ETF inflows are. ETF buying can reflect hedging, de-risking, or mechanical allocation rather than conviction, so the signal is less constructive than it appears. That creates a window to fade crowded beta exposure if the next earnings batch disappoints, while selectively owning sectors with durable capital return and less flow pressure.

Key Decisions for Investors

• Own mega-cap tech into earnings via defined-risk call spreads on QQQ or XLK for the next 2-3 weeks; upside is catalyst-driven, but cut exposure quickly if implied expectations are not clearly beaten.
• Short a basket of elevated-multiple Health Care names or use IHF puts over the next 1-2 months; the flow backdrop is still negative enough that any weak clinical/regulatory news could produce outsized downside.
• Rotate into Financials over Tech on a relative basis via long XLF / short XLK for 4-8 weeks; benefit from better buyback support and less dependence on perfect earnings execution.
• Use any broad-market rally to reduce passive-beta exposure and add hedged longs in cash-generative defensives; the risk/reward favors names with explicit capital return rather than index beta dependent on ETF inflows.
• If post-earnings volatility spikes and tech misses on guidance, add short-dated put spreads on QQQ as a tactical fade; the market is positioned for upside confirmation, not disappointment.